Who Exports Melatonin from India — 116 Suppliers Behind a $9.4M Market
India's melatonin export market is supplied by 116 active exporters who collectively shipped $9.4M across 1,107 shipments. GRACURE PHARMACEUTICALS LIMITED leads with a 24.8% market share, followed by BAROQUE PHARMACEUTICALS PVT LTD and AUROBINDO PHARMA LTD. The top 5 suppliers together control 65.9% of total export value, reflecting a concentrated market structure.
Top Melatonin Exporters from India — Ranked by Export Value
GRACURE PHARMACEUTICALS LIMITED is the leading melatonin exporter from India, holding a 24.8% share of the $9.4M market across 1,107 shipments from 116 exporters. The top 5 suppliers — GRACURE PHARMACEUTICALS LIMITED, BAROQUE PHARMACEUTICALS PVT LTD, AUROBINDO PHARMA LTD, AMOL PHARMACEUTICALS PRIVATE LIMITED, DWD PHARMACEUTICALS LIMITED — collectively control 65.9% of total export value, indicating a moderately concentrated market. Individual shares are: GRACURE PHARMACEUTICALS LIMITED (24.8%), BAROQUE PHARMACEUTICALS PVT LTD (16.5%), AUROBINDO PHARMA LTD (11.3%), AMOL PHARMACEUTICALS PRIVATE LIMITED (7.4%), DWD PHARMACEUTICALS LIMITED (5.9%).
Top Melatonin Exporters from India
Ranked by export value · 116 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | GRACURE PHARMACEUTICALS LIMITED MELOTIN MR -2X15/PAC (MELATONIN 2 MGMELATONIN ARX 2X2X15/PACTERRY WHITE MELATONIN 2 MG MODIFIED RELEASE TABLETS BLISTER | $2.3M | 2 | 24.8% |
| 2 | BAROQUE PHARMACEUTICALS PVT LTD MELATONINA 3MG X 30 CAPMELATONINA CAPSULAS 3MGX30 MELATONIN CAPMELATONINA 3MG X 30 CAP (QTY-166079 BOX/ | $1.5M | 1 | 16.5% |
| 3 | AUROBINDO PHARMA LTD MELATONIN 2MG P/R TAB MELATONIN 2MG P/RTAB 30 BLI PKMELATONIN TABLETS 2 MGMELATONIN 2MG P/R TAB MELATONIN 2MG P/R TAB 30 BLI PK | $1.1M | 4 | 11.3% |
| 4 | AMOL PHARMACEUTICALS PRIVATE LIMITED MELATONIN PLUS GRANULESMELATONIN REGULAR GRANULESMELATONINA RELATED COMPOUND A , | $699.7K | 1 | 7.4% |
| 5 | DWD PHARMACEUTICALS LIMITED MELATONINA 3MG X 30 CAPMELATONINA CAPSULAS 3MGX30 MELATONIN CAPMELATONINA 3MG X 30 CAP (QTY-166079 BOX/ | $551.6K | 1 | 5.9% |
| 6 | V S INTERNATIONAL PRIVATE LIMITED MELATONINA 3MG X 30 CAPMELOTIN MR -2X15/PAC (MELATONIN 2 MGMELATONIN ARX 2X2X15/PAC | $522.4K | 1 | 5.6% |
| 7 | WOCKHARDT LIMITED MELATONIN 2MG P/R TAB MELATONIN 2MG P/RTAB 30 BLI PKMELATONIN 2MG P/R TAB MELATONIN 2MG P/R TAB 30 BLI PKMELATONIN 2MG P R TAB MELATONIN 2MG P R TAB 30 BLI PK | $487.4K | 1 | 5.2% |
| 8 | MEDIBIOS LABORATORIES LIMITED MELATONINA 3MG X 30 CAPMELATONINA CAPSULAS 3MGX30 MELATONIN CAPMELATONINA 3MG X 30 CAP (QTY-166079 BOX/ | $418.9K | 1 | 4.5% |
| 9 | PHOENIX BIOLOGICALS PRIVATE LIMITED MELATONINA 3MG X 30 CAPMELATONINA CAPSULAS 3MGX30 MELATONIN CAPMELATONINA 3MG X 30 CAP (QTY-166079 BOX/ | $389.6K | 1 | 4.1% |
| 10 | BAROQUE PHARMACEUTICALS PRIVATE LIMITED MELATONINA 3MG X 30 CAPMELATONINA CAPSULAS 3MGX30 MELATONIN CAPMELATONINA 3MG X 30 CAP (QTY-166079 BOX/ | $330.2K | 1 | 3.5% |
| 11 | TITAN LABORATORIES PRIVATE LIMITED MELATONIN ZENTIVA 2 MG - 57684 BOXESMELATONIN ZENTIVA LP 57024 BOXES OF 02X 15MELATONIN ZENTIVA 2 MG ) | $262.1K | 2 | 2.8% |
| 12 | SANPRAS HEALTHCARE PRIVATE LIMITED MELATONINA 3MG X 30 CAPMELATONINA CAPSULAS 3MGX30 MELATONIN CAPMELATONINA 3MG X 30 CAP (QTY-166079 BOX/ | $149.7K | 1 | 1.6% |
| 13 | AUROBINDO PHARMA LIMITED MELATONIN 2MG P/R TAB MELATONIN 2MG P/RTAB 30 BLI PKMELATONIN TABLETS 2 MGMELATONIN 2MG P/R TAB MELATONIN 2MG P/R TAB 30 BLI PK | $132.9K | 2 | 1.4% |
| 14 | XL LABORATORIES PRIVATE LIMITED MELATONIN 2MG P/R TAB MELATONIN 2MG P/RTAB 30 BLI PKMELATONIN 2MG P/R TAB MELATONIN 2MG P/R TAB 30 BLI PKMELATONIN 2MG P R TAB MELATONIN 2MG P R TAB 30 BLI PK | $67.8K | 1 | 0.7% |
| 15 | SAVA HEALTHCARE LIMITED MELOSET 3MG 100 TAB MELATONINMELOSET 3MG 100 TAB MELATONINNOSMELOSET 3MG 10 TAB MELATONIN | $48.8K | 1 | 0.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Melatonin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter, June 2019 | Yes | Yes | 100+ | Received FDA warning letter for cGMP violations at Pydibhimavaram facility. |
| Gracure Pharmaceuticals Limited | Not Listed | Yes | Yes | Not verified | WHO-GMP certified manufacturer. |
| Amol Pharmaceuticals Private Limited | Not Listed | Yes | Yes | Not verified | WHO-GMP certified manufacturer. |
| Emcure Pharmaceuticals Limited | Warning Letter, August 20 | Yes | Yes | Not verified | Received FDA warning letter for cGMP violations at Hinjawadi facility. |
| Glenmark Pharmaceuticals Limited | Warning Letter, July 2025 | Yes | Yes | Not verified | Received FDA warning letter for cGMP violations at Madhya Pradesh facility. |
TransData Nexus reviewed the regulatory standing of 5 leading Melatonin exporters from India. 0 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 5 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Melatonin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city hosts over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy's Laboratories and Aurobindo Pharma. The presence of Genome Valley, India's first biotech cluster, further enhances Hyderabad's capabilities in research and development. This robust infrastructure makes Hyderabad a significant contributor to the production of APIs like melatonin.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to major companies such as Cadila Pharmaceuticals and Torrent Pharmaceuticals. The region's well-developed infrastructure, including ports and transportation networks, facilitates efficient manufacturing and export processes.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major commercial hub, provides access to international markets through its extensive port facilities. The region hosts numerous pharmaceutical companies that leverage this strategic location to export products like melatonin to various countries.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, has emerged as a prominent pharmaceutical manufacturing hub, housing over 1,000 pharma units. The region's growth has been bolstered by favorable government policies, including tax incentives and the establishment of a Special Economic Zone (SEZ). These factors have attracted numerous pharmaceutical companies to set up manufacturing facilities in Baddi.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 65.9% of melatonin exports, it's advisable to diversify sourcing to mitigate risks associated with supplier concentration.
- Leverage Regional Specializations: Utilize the strengths of different pharmaceutical clusters—source APIs from Hyderabad and formulations from Ahmedabad-Vadodara—to optimize the supply chain.
- Assess Export Capabilities: Prioritize suppliers in the Mumbai-Thane-Raigad region for their established export infrastructure, ensuring efficient international distribution.
- Evaluate Incentive Benefits: Consider engaging with manufacturers in Baddi-Nalagarh to take advantage of tax incentives and cost-effective production capabilities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Melatonin exporters from India
Aurobindo Pharma Limited — Aurobindo Pharma acquires remaining stake in GLS Pharma
In January 2025, Aurobindo Pharma Limited completed the acquisition of the remaining 49% stake in GLS Pharma, a Hyderabad-based oncology company. This move granted Aurobindo full ownership of GLS Pharma, enhancing its capabilities in oncology active pharmaceutical ingredients (APIs) and formulations. - IMPACT: This acquisition is expected to bolster Aurobindo's oncology portfolio, potentially increasing its production capacity and export capabilities, including melatonin products.
Impact: This acquisition is expected to bolster Aurobindo's oncology portfolio, potentially increasing its production capacity and export capabilities, including melatonin products.
Aurobindo Pharma Limited — Aurobindo Pharma acquires domestic formulations business of Veritaz Healthcare
In March 2025, Aurobindo Pharma Limited acquired the domestic formulations business of Veritaz Healthcare for ₹171 crore. This acquisition aimed to strengthen Aurobindo's presence in the Indian market by expanding its product portfolio and distribution network. - IMPACT: While primarily focused on the domestic market, this acquisition may indirectly enhance Aurobindo's overall production capacity, potentially benefiting its export operations, including melatonin products.
Impact: While primarily focused on the domestic market, this acquisition may indirectly enhance Aurobindo's overall production capacity, potentially benefiting its export operations, including melatonin products.
Aurobindo Pharma Limited — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing
In May 2024, TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma Limited, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: This collaboration is expected to enhance Aurobindo's biologics manufacturing capabilities, which may positively influence its export portfolio, including melatonin products.
Impact: This collaboration is expected to enhance Aurobindo's biologics manufacturing capabilities, which may positively influence its export portfolio, including melatonin products.
Common Questions — Melatonin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which melatonin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, GRACURE PHARMACEUTICALS LIMITED leads with 78 recorded shipments worth $2.3M. BAROQUE PHARMACEUTICALS PVT LTD (28 shipments) and AUROBINDO PHARMA LTD (175 shipments) are also established high-volume exporters.
Q How many melatonin manufacturers are there in India?
India has 116 active melatonin exporters with a combined export market of $9.4M across 1,107 shipments to 51 countries. The top 5 suppliers hold 65.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for melatonin from India?
Average FOB unit price: $2.49 per unit, ranging from $0.00 to $142.31. Average shipment value: $8.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 116 verified Indian exporters of Melatonin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,107 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 51 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,107 Verified Shipments
116 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists